지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Antiplatelet therapies have been widely used to prevent cardiovascular diseases. However, antiplatelet agents causegastrointestinal (GI) damage and are associated with a greater risk of gastroduodenal ulcers and life-threatening ulcercomplications. The first step to reduce the GI risk of antiplatelet therapy is to assess whether the patient requires continuousantiplatelet therapy. The second step is to eliminate risk factors that may place the patient at greater GI risk such as Helicobacterpylori infection, NSAID use, steroid ingestion, and smoking. Continuous aspirin therapy plus a powerful proton pump inhibitor(PPI) is the choice of treatment for antiplatelet-related peptic ulcers. The risk of cardiovascular complications and risk of gastriccomplication using antiplatelet agents should be evaluated individually.
목차
등록된 정보가 없습니다.
참고문헌 (20)
참고문헌 신청
/ 1994 / Collaborative overview of randomised trials of antiplatelet therapy: I. prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in v
ACCF/ACG/AHA / 2008 / 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardio
Chan FK / 2001 / Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen / N Engl J M
Chan FK / 2005 / Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding / N Engl J Med 352 : 238 ~ 244
Chan FK / 2006 / Primer: managing NSAID-induced ulcer complications: balancing gastrointestinal and cardiovascular risks / Nat Clin Pract Gastroenterol Hepatol 3 : 563 ~ 573
ACCF/ACG/AHA / 2008 / 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardio
Chan FK / 2001 / Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen / N Engl J M
Chan FK / 2005 / Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding / N Engl J Med 352 : 238 ~ 244
Chan FK / 2006 / Primer: managing NSAID-induced ulcer complications: balancing gastrointestinal and cardiovascular risks / Nat Clin Pract Gastroenterol Hepatol 3 : 563 ~ 573
이 논문의 저자 정보
최근 본 자료
댓글(0)
0